Abstract. Sulfate is important for growth and development, and is supplied from mother to fetus throughout pregnancy. We used NaS1 sulfate transporter null (Nas1 -/-) mice to investigate the role of NaS1 in maintaining sulfate homeostasis during pregnancy and to determine the physiological consequences of maternal hyposulfataemia on fetal, placental and postnatal growth. We show that maternal serum (≤0.5 mM), fetal serum (<0.1 mM) and amniotic fluid (≤0.5 mM) sulfate levels were significantly lower in pregnant Nas1 -/-mice when compared with maternal serum (≈2.0 mM), fetal serum (≈1.5 mM) and amniotic fluid (≈1.7 mM) sulfate levels in pregnant Nas1 +/+ mice. After 12 days of pregnancy, fetal reabsorptions led to markedly reduced (by ≥50%) fetal numbers in Nas1 -/-mice. Placental labyrinth and spongiotrophoblast layers were increased (by ≈140%) in pregnant Nas1 -/-mice when compared to pregnant Nas1 +/+ mice. Birth weights of progeny from female Nas1 -/-mice were increased (by ≈7%) when compared to progeny of Nas1 +/+ mice. These findings show that NaS1 is essential to maintain high maternal and fetal sulfate levels, which is important for maintaining pregnancy, placental development and normal birth weight. Key words: Placenta, Pregnancy, Sulfate (J. Reprod. Dev. 57: [444][445][446][447][448][449] 2011) ulfate (SO4 2-) is vital for many processes in fetal growth and development, including neurogenesis and steroid metabolism [1] [2] [3] . The ratio of sulfonated (inactive) to unconjugated (active) steroids has important implications for many of the steroid-responsive events that regulate placental and fetal growth [4] . For example, placental estradiol-3-sulfate is taken up by the fetal brain, where it is desulfonated by steroid sulfatase to estradiol, which acts as a potent stimulator of fetal adrenocorticotropin secretion and the hypothalamus-pituitary-adrenal axis [5] . In addition, sulfonation of structural components, such as heparan sulfate proteoglycans (HSPGs), is essential for the maintenance of normal structure and function of placental and fetal tissues [6] . Together, these findings demonstrate an important role for sulfate in maintaining steroid and glycosaminoglycan homeostasis in the developing fetus. SO4 2-is obtained from the diet and from the intracellular metabolism of methionine and cysteine [6] . Circulating SO4 2-levels are maintained by the NaS1 sulfate transporter which is expressed in the kidney where it mediates sulfate reabsorption [7] . During pregnancy, maternal blood sulfate levels increase by approximately 2-fold which provides an essential supply to the placenta and developing fetus [8] [9] [10] [11] . This increase in circulating sulfate level is correlated with increased maternal renal sulfate reabsorption [9, 12] . Since the fetus has a relatively low capacity to form sulfate from methionine and cysteine [13, 14] , most of its sulfate must come from the maternal circulating sulfate pool. These findings are relevant to the decreased fecundity of NaS1 knockout (Nas1 -/-) mice which exhibit both hyposulfataemia and mid-gestational miscarriage [15] . Fetal loss also occurs in heparan (Hs3t1 -/-) and estrogen (Sult1e1 -/-) sulfotransferase null mice [16, 17] , indicating that sulfonation plays a critical role in maintaining pregnancy.
(J. Reprod. Dev. 57: [444] [445] [446] [447] [448] [449] 2011) ulfate (SO4 2- ) is vital for many processes in fetal growth and development, including neurogenesis and steroid metabolism [1] [2] [3] . The ratio of sulfonated (inactive) to unconjugated (active) steroids has important implications for many of the steroid-responsive events that regulate placental and fetal growth [4] . For example, placental estradiol-3-sulfate is taken up by the fetal brain, where it is desulfonated by steroid sulfatase to estradiol, which acts as a potent stimulator of fetal adrenocorticotropin secretion and the hypothalamus-pituitary-adrenal axis [5] . In addition, sulfonation of structural components, such as heparan sulfate proteoglycans (HSPGs), is essential for the maintenance of normal structure and function of placental and fetal tissues [6] . Together, these findings demonstrate an important role for sulfate in maintaining steroid and glycosaminoglycan homeostasis in the developing fetus. SO4 2-is obtained from the diet and from the intracellular metabolism of methionine and cysteine [6] . Circulating SO4 2-levels are maintained by the NaS1 sulfate transporter which is expressed in the kidney where it mediates sulfate reabsorption [7] . During pregnancy, maternal blood sulfate levels increase by approximately 2-fold which provides an essential supply to the placenta and developing fetus [8] [9] [10] [11] . This increase in circulating sulfate level is correlated with increased maternal renal sulfate reabsorption [9, 12] . Since the fetus has a relatively low capacity to form sulfate from methionine and cysteine [13, 14] , most of its sulfate must come from the maternal circulating sulfate pool. These findings are relevant to the decreased fecundity of NaS1 knockout (Nas1 -/-) mice which exhibit both hyposulfataemia and mid-gestational miscarriage [15] . Fetal loss also occurs in heparan (Hs3t1 -/-) and estrogen (Sult1e1 -/-) sulfotransferase null mice [16, 17] , indicating that sulfonation plays a critical role in maintaining pregnancy.
Since NaS1 is not expressed in the placenta or fetus [7, 18] , we used pregnant Nas1 -/-mice as a model for investigating the physiological consequences of maternal hyposulfataemia on placental, fetal and postnatal growth and development. From the matings of Nas1 -/-female × Nas1 +/+ male mice and Nas1 +/+ female × Nas1
-/-male mice, which generates Nas1 +/-progeny in all litters, we show that pregnant Nas1 -/-mice have reduced maternal serum and amniotic fluid sulfate levels throughout pregnancy, negligible fetal serum sulfate levels, increased fetal reabsorptions, decreased fetal/ placental weight ratios, enlarged placental spongiotrophoblast and labyrinth layers and increased post-natal growth in offspring.
Materials and Methods

Animals
All procedures were carried out in accordance with the University of Queensland Animal Ethics Office. We previously generated Nas1 -/-mice in which the NaS1 gene was disrupted by targeted mutagenesis [15] . Male and virgin female mice with a mixed genetic background (129Sv and C57BL/6) were mated overnight using the breeding strategy: Nas1 -/-female × Nas1 +/+ male; and Nas1 +/+ female × Nas1 -/-male. This strategy produces Nas1
progeny in all litters, and compares placental, fetal and post-natal phenotypes between maternal hyposulfataemic Nas1 -/-and normosulfataemic Nas1 +/+ mice. Male Nas1 -/-mice have normal fertility [15] and are therefore unlikely to reduce fecundity in our study. The presence of a copulatory plug in the morning was designated as embryonic day 0.5 (E0.5). Female mice were singly housed in conventional conditions and fed a standard rodent chow (no. AIN93G: Glen Forrest Stockfeeders, Glen Forrest, Western Australia) and water ad libitum. Females were randomly selected on E7.5, E12.5 and E18.5 of pregnancy to be euthanized for analysis of fetal and placental tissues. All procedures were carried out in accordance with the University of Queensland Animal Ethics Office.
Biochemical analyses
Adult mouse blood was collected from the submandibular vein using an animal bleeding lancet (MEDIpoint). Fetal blood was collected immediately following decapitation. Amniotic fluid was collected by needle aspiration. Serum and amniotic fluid sulfate was measured using a modified turbidometric assay as previously described [19] .
Histological analyses
Tissues were dissected into approximately 50 volumes of buffered 10% formaldehyde and fixed for 3 days prior to paraffin embedding. Embedded tissue was sectioned, stained with H&E, and examined by light microscopy.
In situ hybridization
Tissues were dissected into 4% paraformaldehyde in PBS and fixed for 1 day at 4 C. Samples were processed, sectioned and probed with a spongiotrophoblast-specific marker (Prl7a2) as previously described [20] . The labyrinth, spongiotrophoblast and decidua/mesometrial triangle areas were outlined from digital images of the spongiotrophoblast-stained placental sections using a digitizing pen and measured using Image Pro Plus software (Media Cybernetics). A stage micrometer was used to calibrate the measurements.
Quantitative real-time PCR (qRT-PCR) analysis of placental gene expression
Total RNA was isolated from the placentae of female Nas1
and Nas1 -/-mice at 0900 h, using previously described methods [15] . We examined the mRNA levels of 2 placental sulfate transporter genes (Slc13a4 and Slc26a2) and 2 sulfotransferase genes (Sult1e1 and Hs3st1). Total RNA (2 μg) was reverse transcribed by using random hexamers and an Omniscript RT kit (Qiagen) as recommended by the manufacturer. PCR was performed in quadruplicate with 5 μl cDNA (from 25 ng RNA) and 10 μl mastermix containing Fast SYBR Green Master Mix (Applied Biosystems) and 200 nM forward and reverse primers (Supplementary Table 1 ) in a 7500 FAST real time PCR system (Applied Biosystems, Scoresby, Australia). The thermal cycling protocol was: 50 C for 2 min; 94 C for 2 min; 45 cycles of 94 C for 1 sec, 60 C for 10 sec, and 72 C for 15 sec. RNA expression levels and absolute threshold cycle values (Ct values) of each gene were normalised to those of ribosomal RNA with the manufacturer's software (Applied Biosystems). Amplification specificity was confirmed by melting curve analysis and agarose gel electrophoresis.
Behavioural testing
Same-litter groups of male or virgin female mice were housed 2-5 per cage (25 × 42 × 12 cm) at a constant temperature (23 ± 1 C) with a 12 h light/dark cycle (lights on at 0600 and off at 1800 h). To facilitate adaptation, mice were transported to the behavioural studies facility at least 24 h prior to testing. Experiments were conducted between 0800 and 1300 h with the lighting level adjusted to 100 lux. Other than the brief testing periods, mice had access to food and water ad libitum. One group of mice was tested sequentially in the marble bury and open field tests with a one week interval. A second group of mice was tested in the elevated plus maze. Behavioural testing was performed as previously described [21] .
Statistical analyses
Data were analysed using GraphPad Prism (Version 5.01, GraphPad Software, La Jolla, CA, USA). Where data were normally distributed, the statistical significance of differences between Nas1 +/+ and Nas1 -/-groups was assessed by an unpaired Student's t-test, with P<0.05 considered significant. Differences in fetal, placental and maternal weights, and placental areas, were analysed by the Dunnett Multiple comparison test, with P<0.05 considered significant.
Results
Biometry
Fetal numbers and reabsorptions: Previously, we reported reduced litter sizes in progeny from female Nas1 -/-mice (n=4.1 ± 3.9) when compared to Nas1 +/+ (n=10.7 ± 2.5) mice [15] . In order to characterize this further, here we determined the number of fetuses and reabsorption sites in pregnant Nas1
-/-and Nas1 +/+ mice at embryonic days E7.5, E12.5 and E18.5 ( Fig. 1A, B) . At E7.5, we found similar numbers of fetuses and reabsorption sites in pregnant Nas1 -/-and Nas1 +/+ mice. However, fetal numbers were significantly reduced (by ≥50%) in Nas1 -/-mice at E12.5 (median=4, P= 0.003) and E18.5 (median=3, P=0.015) when compared with pregnant Nas1 +/+ mice (median=8). These findings were supported by a significantly increased number of fetal reabsorption sites in pregnant Nas1 -/-mice at E18.5 (Fig. 1B) . Maternal, fetal and placental weights: The increase in body weight of pregnant Nas1 -/-mice at E12.5 (by ≈21%) and E18.5 (by ≈50%) was significantly less than pregnant Nas1 +/+ mice at E12.5 (by ≈31%) and E18.5 (by ≈79%) (Fig. 1C) , which corresponds to the reduced number of fetuses found in Nas1 -/-mice (Fig. 1A) . At E12.5 and E18.5, there were slight (but non-significant) decreases in fetal weights and increased placental weights in pregnant Nas1 -/-mice when compared with Nas1 +/+ mice (data not shown). As an indicator of placental efficiency, we determined the fetal:placental weight ratios. No difference was observed at E12.5 but a significant reduction was observed at E18.5 (by ≈25%, P=0.005) in Nas1 -/-mice (8.9 ± 0.5, n=20) when compared to Nas1 +/+ mice (11.8 ± 0.4, n=42) (Fig. 1D ).
Fetal and placental morphology
The important roles of sulfonation in brain and bone development [3, 22] , led us to compare these tissues in fetuses from pregnant Nas1 -/-and Nas1 +/+ mice. Histological analyses of fetal brain and bone at E12.5 revealed no gross structural differences in Nas1 -/-and Nas1 +/+ mice (data not shown). As placental weights appeared to be slightly increased in pregnant Nas1
-/-mice, we ana-lyzed the morphology of the labyrinth and spongiotrophoblast layers as well as the maternal components of the placenta, the decidua/mesometrial triangle. Spongiotrophoblast staining allowed for the clear demarcation of the placental layers ( Fig.  2A,B) . The decidua/mesometrial triangle area was similar in size between pregnant Nas1 -/-(7.2 ± 0.9 mm 2 ) and Nas1 +/+ (8.4 ± 1.6 mm 2 ) mice, whereas labyrinth and spongiotrophoblast areas were increased by ≈2.4-fold in placentas from pregnant Nas1 -/-mice (5.2 ± 1.7 mm 2 , 3.2 ± 1.0 mm 2 ) when compared to pregnant Nas1 +/+ mice (2.2 ± 0.9 mm 2 , 1.3 ± 0.5 mm 2 ) (Fig. 2C-E ).
Serum and amniotic fluid sulfate levels
In order to determine if body sulfate levels were altered in pregnant Nas1
-/-mice, we measured circulating sulfate levels in pregnant Nas1
-/-and Nas1 +/+ mice at three time points after conception (Fig. 3A) . Day 7.5 was chosen as the earliest time point to study sulfate levels because this gestational age is before signs of reabsorptions at E12.5 (Fig. 1B) . Serum sulfate levels were significantly (P<0.05) increased (by ≈2-fold) in pregnant Nas1 +/+ mice, with levels peaking at E12.5 (2.3 ± 0.8 mM), but remained low (0.5 mM) throughout pregnancy in Nas1 -/-mice (Fig. 3A) . Serum sulfate levels (Fig. 3B) were markedly lower (by ≈30-fold) in E18.5 fetuses from Nas1 -/-mice (0.05 ± 0.01 mM) when compared to Nas1 +/+ mice (1.53 ± 0.20 mM). Amniotic fluid sulfate levels ( Fig.  3C) were significantly lower in Nas1 -/-mice when compared to Nas1 +/+ mice at E12.5 (by ≈3-fold) and at E18.5 (by ≈9-fold).
Placental gene expression
Previously, we showed an altered hepatic transcriptional profile of sulfate transporters and sulfotransferases in Nas1 -/-mice, which we proposed to be a compensatory response to hyposulfataemia [23] . In this study, we quantitated the mRNA levels of two sulfate transporters (Slc13a4 and Slc26a2) and two sulfotransferases (Sult1e1 and Hs3st1), which are normally expressed in mouse placenta [16, 17, [24] [25] , from E12.5 and E18.5 placentae of pregnant Nas1 -/-and Nas1 +/+ mice. No significant differences were found for Slc13a4, Slc26a2, Sult1e1 and Hs3st1 mRNA levels (Supplementary Table 2 ).
Postnatal growth
Our previous findings of growth retardation in Nas1 -/-mice [15] , led us to investigate the consequences of fetal hyposulfataemia (Fig. 3B ) on post-natal growth. As an indicator of growth, we measured the body weights and tail lengths of progeny from Nas1 -/-and Nas1 +/+ mice. At birth, body weights were slightly increased (by ≈7%, P<0.05) in male (1.59 ± 0.04 g, n=25) and female (1.54 ± 0.05 g, n=23) progeny from maternal Nas1 -/-mice when compared to male (1.47 ± 0.02 g, n=31) and female (1.45 ± 0.02 g, n=38) progeny from maternal Nas1 +/+ mice (Fig. 4) . At 1 week of age, body weights of male and female mice were similar between groups, and were not significantly different in male mice up to 16 -/-mice when compared to maternal Nas1 +/+ mice, whereas (E) decidua/mesometrial triangle area were similar in placentae from pregnant Nas1 -/-and Nas1 +/+ mice. Mean ± SD, n=9 per group. **P<0.001, *P<0.01 and NS, non-significant, when compared to placentae from pregnant Nas1 +/+ mice.
weeks. From 5 to 16 weeks of age, body weights were increased (by ≈10%, P<0.05) in the female progeny of maternal Nas1 -/-mice when compared to female progeny from maternal Nas1 +/+ mice (Fig. 4B) . Tails lengths of male and female offspring were similar between groups from 1 to 16 weeks of age (data not shown).
Behavioural studies of progeny from Nas1
-/-and Nas1 +/+ mice
To determine the consequences of maternal and fetal hyposulfataemia on post-natal behaviour, we conducted behavioural testing on the adult progeny of maternal Nas1 -/-and Nas1 +/+ mice. No significant differences were found between groups in the elevated plus maze, open field and marble bury tests (data not shown).
Discussion
In this study, we show markedly reduced sulfate levels in the serum of maternal Nas1 -/-mice and in fetal serum and amniotic fluid of their progeny. From mid-gestation, pregnant Nas1 -/-mice have enhanced fetal reabsorption, enlarged placental labyrinth and spongiotrophoblast layers and decreased fetal numbers. The progeny of maternal Nas1 -/-mice show increased body weight at birth, and female progeny have increased body weight in adulthood. Since all progeny from the reciprocal matings in this study were Nas1 +/-, and because NaS1 is not expressed in the placenta or fetus [7, 18] , we propose that these abnormal features are due to reduced sulfate supply from maternal circulation to the fetoplacental unit as a consequence of maternal hyposulfataemia.
Previous human studies showed that maternal serum sulfate levels increased (by ≈2-fold) during pregnancy [9, 11, 12] . These findings led us to investigate circulating sulfate levels in pregnant Nas1 -/-mice and compare them with pregnant Nas1 +/+ mice. Our data demonstrate that NaS1 is essential for maintaining high maternal circulating sulfate levels throughout pregnancy, and that maternal hyposulfataemia leads to markedly reduced fetal serum and amniotic fluid sulfate levels. This is an important finding because the placenta and fetus have a relatively low capacity to generate sulfate [13, 14] , and rely on a sufficient supply of sulfate from the mother's circulation for sulfonation reactions to function [2] . Whilst the precise effect of hyposulfataemia on sulfonation in the placenta and fetus is at present unclear, our data demonstrate that loss of NaS1 causes reduced fecundity via maternal hyposulfataemia throughout pregnancy which leads to reduced fetal and amniotic fluid sulfate levels in Nas1 -/-mice. Reduced litter sizes arising from Nas1 -/-female mice [15] led us to study the viability and growth of fetuses in pregnant Nas1 -/-and Nas1 +/+ mice at three gestational ages that frame the period of chorioallantoic placental development: E7.5, prior to chorioallontoic attachment and any fetal losses in Nas1 -/-pregnancies; E12.5, when a functional placental labyrinth is present, which is the site of fetal-maternal exchange [26] ; and near the end of gestation at E18.5, when labyrinth development continues and rapid fetal growth is occurring [27] . In this study, we show similar numbers of viable fetuses in pregnant Nas1 -/-and Nas1 +/+ mice at E7.5, indicating no change in fertility in Nas1 -/-mice per se. The reduced number of viable fetuses in pregnant Nas1 -/-mice at E12.5 and E18.5 were similar to the number of live births previously reported [15] , suggesting that fetal loss occurs prior to day E12.5. This conclusion is consistent with the increased fetal reabsorption sites found in pregnant Nas1 -/-mice at E12.5 and E18.5, as well as our earlier observations of blood spotting and miscarriage in Nas1 -/-mice at 14 days of gestation [15] . Whilst fetal numbers were reduced by ≈50% in Nas1 -/-mice at E12.5 and E18.5, we found similar weights of fetuses from Nas1 -/-and Nas1 +/+ pregnant mice. A hallmark feature of normal rodent pregnancy is the inverse relationship between fetal number and weight [28, 29] , which was not found in E12.5 and E18.5 fetuses from pregnant Nas1 -/-mice. This finding implies that the reduced number of surviving fetuses (≈4 per pregnancy) in pregnant Nas1
-/-mice have no growth advantage up to at least E18.5, when compared to fetuses (≈8 per pregnancy) from pregnant Nas1 +/+ mice. This can be relevant to the enlarged labyrinth layer in pregnant Nas1 -/-mice, which may be compensating for a reduction in available sulfate. Enlargement of the labyrinth is proposed to be a physiological adaptation to maximize nutrient transfer in the placenta, as shown in a mouse model of over-expression of maternal IGFBP1 [30] . In addition, since impaired IGF1 expression can reduce fecundity and placental nutrient exchange [31] , it is possible that low levels of IGF1 in Nas1 -/-mice [15] may be a contributing factor to the reduced fecundity and/or altered placental morphometry in pregnant Nas1 -/-mice. To our knowledge, this is the first study to show increased fetal reabsorption and altered placental morphology in a model of maternal hyposulfataemia.
Enlargement of the spongiotrophoblast layer in mouse placentae has been observed in several mouse models with decreased fetal survival, including over-expression of epidermal growth factor receptor [32] , trisomy 15 syndrome [33] and hydroxysteroid 17β dehydrogenase 2 null mice [34] . This is relevant to the enlarged spongiotrophoblast layer in placentae from pregnant Nas1 -/-mice, which have enhanced mid-gestational fetal loss. Spongiotrophoblasts produce numerous proteins with endocrine activity, including cytokines, prolactin-like hormones and lactogens [35] , which are essential for the maintenance and progression of pregnancy and development of the fetus [36] [37] [38] . Whilst the precise mechanism underlying the placental phenotype in Nas1 -/-mice is at present not clear, our data demonstrate maternal hyposulfataemia accompanies an enlarged spongiotrophoblast layer.
Sulfotransferase (Sult1e1, Hs3st1 and Tpst1) null mice exhibit mid-gestational fetal loss [16, 17, 39] , indicating that sulfonation of estrogen, heparan sulfate and tyrosine, is critical for maintaining pregnancy. Our previous study demonstrated increased hepatic sulfotransferase and Sat1 sulfate transporter mRNA levels in Nas1 -/-mice [23] , suggesting that sulfotransferase and sulfate transporter mRNA expression is sensitive to changes in blood sulfate levels. In this study we investigated the mRNA expression of two sulfotransferases (Sult1e1 and Hs3st1) and two sulfate transporters (NaS2 and Slc26a2), which are expressed in the placenta [16, 17, 24, 25] . However, our data show no change in Sult1e1, Hs3st1, NaS2 and Slc26a2 mRNA expression, indicating that these genes in the placenta are not sensitive to changes in maternal circulating sulfate levels.
The abnormal prenatal phenotypes of placental and fetal tissues from pregnant Nas1 -/-mice led us to investigate the postnatal growth of progeny from Nas1 -/-and Nas1 +/+ female mice. Whilst the median fetal weight was similar in pregnant Nas1
-/-and Nas1 +/+ mice at E18.5, we found significantly increased (by ≈7%) birth weights of male and female progeny from maternal Nas1 -/-mice when compared to the progeny of maternal Nas1 +/+ mice, suggesting late prenatal accelerated growth in pregnant Nas1 -/-mice. Previous studies showed accelerated fetal growth from mid-to lategestation [40] and a greater mass at weaning [41] in the progeny of rats fed on a low protein diet during pregnancy. Interestingly, the body mass of female progeny from maternal Nas1 -/-mice was increased (by 10%) from 5 weeks of age when compared to female progeny of maternal Nas1 +/+ mice, which was not observed between male progeny from maternal Nas1 -/-and Nas1 +/+ mice, indicating that male and female progeny may not have identical responses to maternal hyposulfataemia. Previous studies have shown that female post-natal growth is more responsive to intrauterine stressors when compared to males [42] , suggesting that gender differences are associated with metabolic programming in the developing fetus.
Our earlier studies showed behavioural abnormalities in Nas1
-/-mice, including reduced object anxiety and locomotor activity [21] . In this study, we found no behavioural differences between adult progeny from maternal Nas1 -/-and Nas1 +/+ mice in marble bury, elevated plus maze and open field tests, which are used to assess anxiety-like behaviours in rodents [43] [44] [45] . These findings indicate that exposure to maternal and fetal hyposulfataemia does not lead to anxiety-like symptoms in the adult progeny from Nas1 -/-female mice.
In summary, this study shows that NaS1 is essential for maintaining high circulating sulfate levels during pregnancy and that maternal hyposulfataemia leads to mid-gestational fetal loss, altered placental development and increased birth weights. These findings are relevant to diet, hormones and analgesics which regulate blood sulfate levels [46] , prompting future assessment of preand post-natal development in humans with altered sulfate homeostasis.
